VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMRXAmneal Pharmaceuticals, Inc.
$20.14$6.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMRXQuarterly Cash Flow

Amneal Pharmaceuticals, Inc. (AMRX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Amneal Pharmaceuticals, Inc. (AMRX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

AMRX Cash Flow Statement

Quarterly statement

AMRX Cash Flow Statement

Amneal Pharmaceuticals, Inc. (AMRX) cash flow statement — 11-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations100.28M-19.26M-28.73M130.31M118.45M83.82M7.41M118.08M141.77M39.66M-4.41M135.82M81.39M-11.35M139.71M-23.29M93.57M-125.52M76.34M63.26M
Operating CF Margin %11.62%-2.42%-3.98%16%15.1%11.57%1.07%16.16%20.18%5.65%-0.67%22.01%13.13%-1.89%25.06%-3.82%17.15%-22.44%15.34%11.78%
Operating CF Growth %-15.34%-122.98%-487.76%10.36%-16.45%111.36%267.98%-13.06%74.2%449.55%-103.16%683.13%-13.02%90.96%83%-136.82%13.61%-141.7%-48.46%-40.3%
Net Income12.31M69.61M78M49.57M18.13M35.61M24.62M-20.74M11.76M5.99M-81.68M-93.34M25.03M29.68M-10.09M-4.33M-2.69M-240.08M-2.16M-6.38M
Depreciation & Amortization53.26M47.8M43.19M49.23M54.07M60.11M60.16M66.13M58.96M55.57M55.53M56.93M57.21M57.11M58.15M63.16M63.71M59.7M57.81M63.51M
Stock-Based Compensation10.52M10.39M08.2M8.22M8.27M7.26M7.21M7.11M6.72M6.72M5.97M6.69M6.56M7.6M7.83M7.69M8.26M07.74M
Deferred Taxes2.75M000-23.36M000000000000000
Other Non-Cash Items50.66M44.44M40.17M35.6M112.12M14.93M21.75M43.63M21.18M87.94M26.99M112.56M27.2M15.73M29.78M-10.61M-89.32M27.66M-29.97M9.02M
Working Capital Changes-29.21M-191.51M-190.08M-12.29M-50.74M-35.11M-106.38M21.86M42.77M-116.57M-11.97M53.7M-34.74M-120.43M54.28M-79.34M114.18M18.94M50.66M-10.63M
Change in Receivables3.52M-169.7M43.96M-9.52M-77.33M-54.87M21.15M-27.64M21.96M-100.67M-55.73M77.88M-19.4M-129.11M196.44M-113.29M60.13M-150.99M124.27M-34.52M
Change in Inventory-34.2M-69.19M-54.96M-20.18M-30.81M-22.78M-13.26M-51.98M-43.1M-23.25M-12.2M-23.09M-42.57M-38.02M-22.51M-11.07M-25.93M-39.85M-25.55M16.63M
Change in Payables75.51M66.66M-124.58M18.58M69.75M45.62M-112.63M66.26M46.85M062.17M-19.76M33.08M42.72M-150.48M00322.72M-48.78M0
Cash from Investing-471.83M-122.74M-21.71M-45.45M-22.46M-26.55M-17.8M-16.06M-20.71M-6.46M-19.76M-31.69M-13.48M-12.28M-11.74M-11.47M-49.33M-16.12M-97.39M-86.97M
Capital Expenditures-51.19M-122.74M-21.71M-46.17M-15.05M-27.4M-13.16M-22.46M-17.11M-10.7M-10.06M-11.79M-12.48M-11.13M-11.4M-11.47M-17.53M-7.12M-10.79M-18.05M
CapEx % of Revenue5.93%15.42%3%5.67%1.92%3.78%1.89%3.08%2.44%1.53%1.53%1.91%2.01%1.86%2.04%1.88%3.21%1.27%2.17%3.36%
Acquisitions-420.65M00715K0855K07M0000000000-84.71M-72.72M
Investments--------------------
Other Investing0000-7.41M0-4.64M-600K-3.6M4.24M-9.7M-19.9M-1M-1.15M-338K0-31.8M-9M-1.89M3.8M
Cash from Financing412.8M77.38M-57.07M-10.12M59.44M-41.69M-39.17M-61.2M-92.35M-35.09M-23.16M-100.83M-86.58M-12.26M-12.9M-22.17M-46.13M23.25M-17.57M-30.35M
Debt Issued (Net)421.49M91.83M-6.17M-6.12M67.21M-17.29M-17.53M-55.53M-87.21M-27M-15.38M64.16M-53.94M5.09M7.34M-17.65M-42.61M31.79M-9.8M-9.85M
Equity Issued (Net)436K42K38K553K653K685K69K0-194K-159K28K0000-88K-192K0111K-69K
Dividends Paid00000000000000000000
Share Repurchases00000000-194K-159K00000-88K-192K00-69K
Other Financing-9.12M-14.5M-50.94M-4.55M-8.42M-25.08M-21.71M-5.67M-4.94M-7.93M-7.81M-164.99M-32.64M-17.35M-20.24M-4.42M-3.33M-8.54M-7.89M-20.43M
Net Change in Cash35.29M-65.55M-109.04M74.89M154.79M15.42M-50.03M40.08M28.72M-2M-47.49M3.5M-18.98M-36.49M115.84M-60.66M-2.29M-118.36M-40.19M-53.88M
Free Cash Flow60.7M-64.85M-42.59M87.15M103.4M57.32M-10.91M95.01M121.06M28.95M-24.17M104.13M67.91M-23.63M127.97M-34.76M76.04M-142.64M65.55M45.21M
FCF Margin %7.04%-8.15%-5.89%10.7%13.18%7.91%-1.57%13.01%17.23%4.13%-3.67%16.88%10.95%-3.94%22.95%-5.7%13.94%-25.5%13.17%8.42%
FCF Growth %-41.3%-213.15%-290.19%-8.28%-14.59%97.97%54.84%-8.76%78.27%222.53%-118.89%399.59%-10.69%83.43%95.23%-176.89%6.02%-138.75%-51.92%-39.93%
FCF per Share0.18-0.20-0.130.270.320.18-0.030.310.390.09-0.080.430.43-0.150.84-0.230.50-0.940.440.30
FCF Conversion (FCF/Net Income)-13.45x-0.33x-0.46x3.72x50.00x3.74x0.61x-3.80x-908.81x6.62x0.05x-1.38x8.41x-0.95x-20.12x5.38x-34.80x1.04x-35.41x-9.92x
Interest Paid0000056.32M56.32M60.6M66.37M72.03M64.51M56.21M47.9M47.64M41.07M50.51M34.89M30.03M030.07M
Taxes Paid000008.95M3.61M6.16M-1.15M04.57M2.07M-3.49M0000000